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ABSTRACT Multidrug efflux systems are a major cause of resistance to antimicrobials in bacteria, including those pathogenic to
humans, animals, and plants. These proteins are ubiquitous in these pathogens, and five families of bacterial multidrug efflux
systems have been identified to date. By using transcriptomic and biochemical analyses, we recently identified the novel AceI
(Acinetobacter chlorhexidine efflux) protein from Acinetobacter baumannii that conferred resistance to the biocide chlorhexi-
dine, via an active efflux mechanism. Proteins homologous to AceI are encoded in the genomes of many other bacterial species
and are particularly prominent within proteobacterial lineages. In this study, we expressed 23 homologs of AceI and examined
their resistance and/or transport profiles. MIC analyses demonstrated that, like AceI, many of the homologs conferred resistance
to chlorhexidine. Many of the AceI homologs conferred resistance to additional biocides, including benzalkonium, dequalinium,
proflavine, and acriflavine. We conducted fluorimetric transport assays using the AceI homolog from Vibrio parahaemolyticus
and confirmed that resistance to both proflavine and acriflavine was mediated by an active efflux mechanism. These results show
that this group of AceI homologs represent a new family of bacterial multidrug efflux pumps, which we have designated the pro-
teobacterial antimicrobial compound efflux (PACE) family of transport proteins.
IMPORTANCE Bacterial multidrug efflux pumps are an important class of resistance determinants that can be found in every bac-
terial genome sequenced to date. These transport proteins have important protective functions for the bacterial cell but are a
significant problem in the clinical setting, since a single efflux system can mediate resistance to many structurally and mechanis-
tically diverse antibiotics and biocides. In this study, we demonstrate that proteins related to the Acinetobacter baumannii AceI
transporter are a new class of multidrug efflux systems which are very common in Proteobacteria: the proteobacterial antimicro-
bial compound efflux (PACE) family. This is the first new family of multidrug efflux pumps to be described in 15 years.
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Multidrug efflux is a ubiquitous mechanism of drug resistancein bacterial pathogens that is mediated by integral mem-
brane transport proteins. These proteins are typically very pro-
miscuous, recognizing a range of antimicrobial substrates that dif-
fer in both structure and valency. To date, five distinct families of
transport proteins have been shown to include multidrug efflux
systems: the major facilitator superfamily, the resistance/nodula-
tion/division superfamily, the ATP-binding cassette superfamily,
the multidrug and toxic compound extrusion family, and the
small multidrug resistance family.
Recently, we identified the aceI (Acinetobacter chlorhexidine
efflux) gene in Acinetobacter baumannii, which is involved in
adaptive resistance to the widely used biocide chlorhexidine (1).
This gene was overexpressed more than 10-fold in response to a
subinhibitory shock of chlorhexidine in A. baumannii ATCC
17978. The aceI gene encodes a membrane protein that is approx-
imately 150 amino acid residues in length and contains two tan-
dem bacterial transmembrane pair (BTP; Pfam accession number
PF05232) domains (2). Heterologous expression of aceI increased
Escherichia coli resistance to chlorhexidine (1) and, conversely,
deletion of aceI from the A. baumannii genome increased its sus-
ceptibility to chlorhexidine (3). The AceI protein was shown to
interact directly with chlorhexidine and to mediate its efflux via an
energy-dependent mechanism (1). However, resistance to other
antimicrobial compounds was not observed (1).
Genes that encode BTP domain proteins homologous to aceI
are carried by diverse bacterial species but are particularly com-
mon among proteobacterial lineages. Similar to A. baumannii,
genes encoding BTP domain proteins were upregulated in the
human pathogens Pseudomonas aeruginosa PAO1 and Burkhold-
eria cenocepacia J2315 in response to chlorhexidine and were able
to mediate resistance to this biocide (1). Furthermore, related BTP
domain protein genes from the soil bacterium Acinetobacter baylyi
ADP1 and the plant commensal bacterium Pseudomonas protegens
Pf-5 were also shown to mediate resistance to chlorhexidine when
expressed in E. coli (1). Deletion of this gene from A. baylyi ADP1
increased its susceptibility to chlorhexidine (1).
In addition to aceI, the A. baumannii genome harbors a second
gene that encodes a BTP family protein, A1S_1503, that does not
confer chlorhexidine resistance and whose expression is not in-
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duced by chlorhexidine. Similarly, P. protegens harbors a second
gene encoding a BTP domain protein that appears to be nonfunc-
tional with respect to chlorhexidine resistance (1), and the
P. aeruginosa and B. cenocepacia genomes carry one or two BTP
domain protein genes that are not induced by chlorhexidine (4, 5).
Here, we sought to identify alternative drug substrates for BTP
domain proteins. We demonstrate that, in addition to chlorhexi-
dine, many BTP domain proteins are able to mediate resistance to
other biocides, as well as fluorescent dyes. The protein from Vibrio
parahaemolyticus VP1155 provided particularly strong resistance
to biocides and dyes and mediated rapid transport of acriflavine
and proflavine. These results indicate that BTP domain proteins
represent a new family of transport proteins that includes multi-
drug efflux systems, which we have designated the proteobacterial
antimicrobial compound efflux (PACE) family.
BTP protein gene cloning and expression. At the time of writ-
ing, the Pfam database (version 27.0) listed close to 800 proteins
that contain BTP domains from more than 600 bacterial species
(2). The majority (95%) of these proteins were predicted to have
the same tandem BTP domain architecture as AceI and were en-
coded by Proteobacteria, particularly the gamma, beta, and alpha
subdivisions (although this may be biased by the species for which
genome sequence data are available). In addition to Proteobacte-
ria, the genomes of several Veillonella and Micrococcus species
(Firmicutes and Actinobacteria, respectively) also carried BTP do-
main protein genes. We have not, however, detected these genes in
the genomes of archaeal or eukaryotic organisms.
In this study, we examined the drug resistance/transport capa-
bilities of 24 BTP domain proteins, including AceI. These proteins
were selected to encompass the full spectrum of currently sampled
phylogenetic diversity within this group (Fig. 1) and included 18
gammaproteobacterial proteins, 3 betaproteobacterial proteins,
and 1 representative protein from each of Alphaproteobacteria,
Firmicutes, and Actinobacteria (Table 1). Seven of the genes encod-
ing these proteins were previously cloned into the E. coli pTTQ18
expression vector via conventional methods (1). The remaining
17 were synthetically designed E. coli codon-optimized sequences
and were synthesized in single gBlock gene fragments (Integrated
DNA Technologies) and then cloned into the pTTQ18 plasmid
vector (6). With the exception of Vpar_0264, ROS217_23162 and
MHA_0890, the proteins under investigation were expressed at
levels detectable in Western blot assays of whole-cell lysates (see
Fig. S1 in the supplemental material). This level of expression
success (87.5%) is in line with our previous experiences using this
expression system for the heterologous production of transport
systems (7–9).
Chlorhexidine resistance mediated by AceI homologs. Previ-
ously, we demonstrated that BTP domain proteins homologous
to the A. baumannii AceI protein from A. baylyi ADP1
(ACIAD1978), P. aeruginosa PA14 (PA14_26850), P. protegens
FIG 1 Tree showing the phylogenetic relationships of BTP family proteins included in this study. The tree was generated using MrBayes 3.2.1 (14) from a
ClustalX2 alignment of protein sequences obtained from the National Center for Biotechnology Information database. Interior node values are clade credibility
values (posterior probabilities) generated and assigned by MrBayes.
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Pf-5 (PFL_4558), and B. cenocepacia HI2424 (Bcen2424_2356)
were able to confer resistance to chlorhexidine, whereas the phy-
logenetically distinct (Fig. 1) proteins from A. baumannii
(A1S_1503) and P. protegens (PFL_4585) did not confer resistance
(1). Chlorhexidine MIC analyses were conducted as previously
described (8) to gauge the level of resistance provided by the 17
newly cloned BTP domain protein homologs. These assays were
conducted in medium containing 0.05 mM isopropyl--D-
thiogalactopyranoside (IPTG) to induce basal levels of expression.
Among the 24 cloned genes, we saw reproducible increases in
chlorhexidine resistance from 12 genes (Table 1). This result con-
firmed that chlorhexidine is a common substrate of this group of
transporters.
BTP domain proteins are multidrug efflux systems. To ex-
plore the possibility that BTP domain proteins represent a new
family of multidrug efflux transporters, we tested their capacities
to confer resistance to a range of additional antimicrobial com-
pounds in MIC analyses. These compounds included: the biocides
dequalinium, tetraphenylphosphonium, and benzalkonium, the
antibiotics tetracycline and chloramphenicol, and a number of
fluorescent antimicrobial dyes that are common substrates of
multidrug efflux systems, such as proflavine, acriflavine,
ethidium, Hoechst 33342, pyronin Y, acridine yellow, and 4=,6-
diamidino-2-phenylindole (Table 1).
Resistance to a variety of antimicrobials was common, partic-
ularly among the Pseudomonas and betaproteobacterial genes
(Table 1). Six BTP domain protein genes conferred reproducible
resistance to the biocide benzalkonium. Additionally, two Pseu-
domonas proteins, PA14_26850 and PFL_4585, mediated resis-
tance to dequalinium. Notably, PFL_4585 is a paralog of the
chlorhexidine resistance protein PFL_4558, demonstrating that
both BTP domain proteins encoded by P. protegens Pf-5 mediate
resistance to selected biocides. Nine of the BTP domain protein
genes also conferred resistance to one or both of the DNA-
intercalating antimicrobial dyes acriflavine and proflavine (Ta-
ble 1). Only 6 genes out of the 24 examined in this study did not
provide resistance to any of the antimicrobials tested. Of these,
three were not expressed at levels detectable by Western blotting
(see Fig. S1 in the supplemental material). The V. parahaemolyti-
cus gene VP1155 provided the highest and most consistent in-
creases in resistance to the greatest number of compounds, with at
least 4-fold increases in resistance to chlorhexidine, benzalko-
nium, proflavine, and acriflavine. To determine whether resis-
tance mediated by these proteins was dependent on a TolC-like
outer membrane, we examined resistance mediated by AceI and
VP1155 in a TolC-inactivated background (10). Both of these pro-
teins mediated resistance in this mutant strain.
To explore further the substrate recognition profile of the
VP1155 protein, we conducted Biolog OmniLog Phenotype mi-
croarray (PM) experiments (11). The resistance levels of E. coli
BL21 carrying pTTQ18-VP1155 were compared to those of E. coli
BL21 carrying pTTQ18 for 240 different antimicrobials in the




MIC or MIC range (g/ml)b
CH DQ BK PF AF
NA (negative control) NAc (vector only) 0.195–0.39 50 0.39–0.78 6.25 3.125
Acinetobacter baumannii ATCC 17978 A1S_2063 (aceI) 1.56 12.5-25 0.39–0.78 6.25 3.125
Acinetobacter radioresistens SH164 HMPREF0018_01702 0.78 25 0.39–0.78 6.25 3.125
Acinetobacter baylyi ADP1 ACIAD1978 0.78 50 0.78 6.25 3.125
Mannheimia haemolytica PHL213 MHA_0890 0.39 50 0.78 6.25 3.125
Pseudoalteromonas sp. BSi20429 P20429_2969 0.195 50 0.78 6.25 6.25
Veillonella parvula DSM 2008 Vpar_0264 0.195 50 0.39–0.78 6.25 3.125
Vibrio parahaemolyticus RIMD 2210633 VP1155 1.56 50 3.125 25 12.5
Ferrimonas balearica DSM 9799 Fbal_3166 0.78–1.56 50 0.78 3.125 6.25
Micrococcus luteus NCTC 2665 Mlut_15630 0.195 50 0.39–0.78 6.25 3.125
Acinetobacter baumannii ATCC 17978 A1S_1503 0.195 25 0.78 6.25 6.25
Pseudomonas protegens Pf-5 PFL_4585 0.195 100 1.56 3.125–6.25 3.125
Tepidiphilus margaritifer DSM 15129 655492601d 0.195 50–100 0.78–1.56 1.56–3.125 3.125
Roseovarius sp. 217 ROS217_23162e 0.195 50 0.78 6.25 3.125
Pseudomonas aeruginosa PA14 PA14_26850 0.78 100 1.56 6.25 3.125
Ralstonia solanacearum PSI07 RPS107_mp1531 0.195–0.39 50–100 1.56–3.125 3.125 6.25
Burkholderia cenocepacia HI2424 Bcen2424_2356 1.56 25 1.56–3.125 12.5–25 6.25
Pseudomonas protegens Pf-5 PFL_4558 1.56 12.5-25 0.39–0.78 3.125–6.25 3.125
Pseudomonas syringae pv. Tomato strain DC3000 PSPTO_3587 0.78 50 0.78 12.5–25 6.25
Pseudomonas putida KT2440 PP_3512 0.78 50 0.78–1.56 6.25 3.125
Enterobacter cloacae SCF1 Entcl_2273 0.39 25 1.56 6.25 3.125
Yokenella regensburgei ATCC 43003 HMPREF0880_01962 0.78 50 0.78–1.56 3.125–6.25 3.125
Klebsiella pneumoniae 342 KPK_0842 0.78 25 0.78–1.56 12.5 3.125
Salmonella enterica subsp. enterica serovar Typhi strain ct18 STY3166 0.195 25–50 0.39 6.25 3.125
Escherichia coli TW07793 ECTW07793_0407 0.39–0.78 50 0.78 6.25–12.5 6.25
a None of the cloned BTP family genes conferred reproducible resistance to tetracycline, chloramphenicol, tetraphenylphosphonium, ethidium, Hoechst 33342, pyronin Y, acridine
yellow, or 4=,6-diamidino-2-phenylindole.
b The values given are from at least two independent biological replicates, and those indicating reproducible increases in resistance are shown in boldface. Abbreviations: CH,
chlorhexidine; DQ, dequalinium; BK, benzalkonium; PF, proflavine; AF, acriflavine.
c NA, not applicable.
d The GenBank protein ID is given for the Tepidiphilus margaritifer DSM 15129 protein.
e The cloned Roseovarius sp. 217 gene ROS217_23162 contains a single base change that results in a serine-to-phenylalanine mutation at position 139 (C-terminal tail).
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PM11-20 plate series, as previously described (1, 11). These tests
confirmed that VP1155 provides resistance to the substrates iden-
tified by conventional MIC assays: chlorhexidine, proflavine, and
acriflavine (see Fig. S2 in the supplemental material; benzalko-
nium is not included in the PM11-20 panel of compounds). Fur-
thermore, the Biolog PM tests indicated that VP1155 also provides
resistance to 9-aminoacridine, domiphen bromide, 3,5-diamino-
1,2,4-triazole (guanazole), and plumbagin (see Fig. S2).
Fluorimetric transport assays demonstrate efflux mediated
by VP1155. The observations of resistance to the DNA-
intercalating antimicrobial dyes proflavine and acriflavine from
several of the BTP domain protein genes presented the opportu-
nity to assay directly the efflux of these substrates in real-time
fluorimetric transport assays. We applied these assays to cells ex-
pressing VP1155, exploiting the capacity of this protein to mediate
resistance to both dyes. The assays were conducted in the E. coli
triple deletion mutant strain BW25113 (acrB emrE mdfA::
kan), which is defective in the three major E. coli multidrug efflux
system genes (12) and provides a sensitive background for these
assays. Cells carrying the pTTQ18-VP1155 expression plasmid
were assayed both pre- and postinduction of VP1155 expression
by using 0.2 mM IPTG (see Fig. S3 in the supplemental material).
Cells carrying “empty” pTTQ18 treated with IPTG were also in-
cluded as a negative control. The transport assays were conducted
essentially as described previously (13), except that cells were
grown in glycerol-supplemented medium and reenergized by us-
ing glycerol to initiate transport from substrate-loaded cells.
The fluorescence intensity of both proflavine and acriflavine is
lower when intercalated into DNA, so efflux from the cell was
characterized by an increase in fluorescence over time. In our
transport experiments we observed a rapid increase in fluores-
cence in cells that expressed the VP1155 protein but not in control
cells lacking this protein (Fig. 2; see also Fig. S3 in the supplemen-
tal material). These results provide additional evidence that efflux
is the mechanism of resistance operating in this group of proteins.
Conclusions. In this study, we examined a large panel of genes
encoding proteins related to the AceI chlorhexidine efflux system
for their ability to confer resistance to a set of 12 different biocides,
antibiotics, and antimicrobial dyes. To facilitate this broad survey
of phylogenetically diverse proteins, we adopted a synthetic clon-
ing approach; the majority of genes were codon optimized for
expression in E. coli and chemically synthesized for cloning into
our expression system. Of the 24 transport proteins studied, 21
were expressed at levels detectable in Western blot assays of
whole-cell lysates, and 18 conferred resistance to one or more
antimicrobial compounds.
Our results demonstrate that this group of proteins is a new
family of bacterial multidrug efflux systems, which we have desig-
nated the proteobacterial antimicrobial compound efflux (PACE)
family. The PACE family is only the sixth family of bacterial mul-
tidrug efflux systems to have been described and the first new
family for more than 15 years. Multidrug efflux systems encoded
by nosocomial pathogens are particularly problematic. Antimi-
crobial pressures selecting for increased expression of multidrug
exporters can promote resistance to not only the selecting com-
pound but also to a swath of otherwise-effective compounds.
Using a radiolabeled substrate, we previously demonstrated
that the AceI protein within the PACE family is able to mediate the
active efflux of chlorhexidine. In this work, we have identified
fluorescent substrates for several members of the PACE family
that facilitate the development of rapid fluorimetric efflux assays.
These assays will be highly valuable in future studies to define the
molecular transport mechanism operating in members of this
family, including the mode of energization, which is likely to in-
volve an electrochemical gradient.
Notably, PACE family proteins are encoded in the core ge-
nomes of many proteobacterial species that are separated by hun-
dreds of millions of years of evolution. Given that the substrates
we have now defined for these efflux systems— chlorhexidine, de-
FIG 2 Acriflavine and proflavine efflux mediated by VP1155. E. coli
BW25113 acrB emrE mdfA::kan cells carrying pTTQ18 only (black line)
or pTTQ18-VP1155 (blue [noninduced] and red [induced]) were grown in
Luria-Bertani medium containing 0.5% glycerol to an optical density at 600
nm of 0.6. Samples of pTTQ18-VP1155 cells were taken and assayed as non-
induced controls (blue lines). The cultures were then grown for a further 1 h,
after which 0.2 mM IPTG was added to induce expression directed by the Ptac
promoter in pTTQ18. The cells were washed in assay buffer (HEPES, pH 7.0)
and loaded with 20 M acriflavine (A) or proflavine (B) in the presence of the
protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP). The
loaded cells were again washed and suspended in assay buffer (37°C). Trans-
port was initiated with the addition of 1% glycerol at the point marked with an
arrow. The assays were performed in biological triplicates, and the error bars
show the standard errors of the means at 1-min intervals. Expression of the
RGSH6-tagged VP1155 protein in the samples was assessed by Western blot-
ting (see Fig. S3 in the supplemental material) and was positively correlated
with efflux.
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qualinium, benzalkonium, proflavine, and acriflavine—are syn-
thetic biocides that have only been widely used within the last
century, it seems unlikely that these compounds are the physio-
logical substrates of these transporters. Nonetheless, as with other
multidrug efflux systems, the substrate promiscuity of PACE ef-
flux systems is likely to have enhanced the success of proteobacte-
rial pathogens in clinical settings.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
lookup/suppl/doi:10.1128/mBio.01982-14/-/DCSupplemental.
Figure S1, TIF file, 1.4 MB.
Figure S2, TIF file, 1.8 MB.
Figure S3, TIF file, 0.6 MB.
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